, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ: FTNT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e- mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Fortinet and certain of its officers and/or director ...

The Federal Reserve on Wednesday released the minutes from the central bank's monetary policy meeting last month, which showed that while policymakers anticipate further interest rate cuts, they remain committed to bringing inflation back to its 2% target. The Federal Open Market Committee (FOMC), which guides the Fed's monetary policy moves, voted in September to lower the benchmark federal funds rate by 25 basis points to a range of 4% to 4.25%. That move cut interest rates for the first time in 2025, but ...

All right, we're back on the belltech earnings kickoff in just a few weeks. Our next guest says it will be a popcorn moment for AI. Joining me now, Wed Bush's Dan Ives.It's good to see you. I don't think anybody is really surprised to hear you say that given how bullish you've been. Is there a name that you're most bullish about of all the companies that you cover and people are so used to hearing you speak about.Scott, I'd say look about 30% of the deals have been accelerated on the Microsoft side. I think ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

About Rollins, Inc. , /PRNewswire/ -- Rollins, Inc. (NYSE:ROL) ("Rollins" or the "Company"), a premier global consumer and commercial services company, today announced that it will release its third quarter results for the period ended September 30, 2025, after the market closes on Wednesday, October 29, 2025. In conjunction with its release, the Company will host a conference call to review the Company's financial and operating results before the market opens on Thursday, October 30, 2025, at 8:30 a.m. Ea ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals' immunotherapy, Libtayo, as an add-on treatment for skin cancer patients at high risk of their disease returning after surgery and radiation, the drugmaker said. ...